ArticleFrontiers in oncology2019

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma.

Xiangyang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.